Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-24

FDA Approved: CEVIMELINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for cevimeline hydrochloride from Rising Pharma Holdings, Inc., confirming changes to the product's regulatory status. C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cevimeline hydrochloride (cevimeline hydrochloride)

Snippet

SUPPL AP for CEVIMELINE HYDROCHLORIDE (CEVIMELINE HYDROCHLORIDE)